Market by Product, Modality, Type, Application, End-user, and Country | Forecast 2021-2028
The
Asia-Pacific cartilage repair market is envisioned to exhibit growth at 17.02%
of CAGR during the reviewed period 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries considered in this market include:
• India
• China
• Japan
• Australia & New Zealand
• South Korea
• ASEAN countries
• Rest of APAC
The
cartilage repair market has observed a significant growth rate across the
region, owing to the high population base and growing occurrence of osteoarthritis
and joint-related diseases. Moreover, a surge in R&D activities by current
market players regarding cartilage repair therapies is also fueling the studied
market’s progress across the APAC region.
Furthermore,
there is a rise in the number of geriatric populations, which is likely to
increase the need for orthopedic surgeries across China. Since the country is
among the most populated countries globally, the demand for cartilage repair
products is anticipated to grow over the next few years. Along with this, the
increase in R&D activities is promoting the progress of the studied market
over the estimated period. For instance, a group of researchers developed
injectable cartilage used in tissue repair and plastic surgery. The low cost
required to produce cartilage repair products is another factor propelling the
Chinese cartilage repair market on a growth path.
In
India, the enhancements in healthcare infrastructure and rise in healthcare
spending to overcome the unmet medical requirements are anticipated to amplify
the demand for cartilage repair products. Besides, the high incidence of
unintentional trauma injuries has triggered the need for cartilage repair
products, thereby contributing to the evolution of the Indian cartilage repair
market.
Medtronic Plc is a medical technology and
services company engaged in manufacturing, developing, and marketing devices
and technologies to a large consumer base. It primarily serves hospitals,
clinics, distributors, and other institutions. Among its products, infuse bone
graft is a premium product used for autograft replacement. Medtronic has
business operations in multiple regions, including Asia-Pacific.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
CARTILAGE REPAIR MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. KEY
INSIGHTS
2.1.1. ADVANCEMENTS
IN TECHNOLOGY AND TECHNIQUES IN SPORTS MEDICINE
2.1.2. ESCALATING
TRAUMA CASES
2.2. IMPACT
OF COVID-19 ON CARTILAGE REPAIR MARKET
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRY
2.3.2. THREAT
OF SUBSTITUTION
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. MARKET
ATTRACTIVENESS MATRIX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. CONTRACTS
& PARTNERSHIPS
2.6.2. BUSINESS
EXPANSIONS & DIVESTITURES
2.6.3. ACQUISITIONS
& MERGERS
2.6.4. NEW
PRODUCT LAUNCHES
2.7. KEY
DRIVERS
2.7.1. HIGH
PREVALENCE OF OBESITY
2.7.2. SPORTS-RELATED
INJURIES
2.7.3. GROWTH
IN ELDERLY POPULATION
2.8. KEY
RESTRAINTS
2.8.1. HIGH
COST OF CARTILAGE REPAIR SURGERIES
2.8.2. LACK
OF FAVORABLE REGULATION FOR THE USE OF CARTILAGE REPAIR PRODUCTS
2.9. KEY
OPPORTUNITIES
2.9.1. LUCRATIVE
OPPORTUNITIES FOR CARTILAGE REPAIR IN DEVELOPING NATIONS
2.9.2. PREFERENCE
FOR MINIMALLY INVASIVE TECHNIQUES
3. ASIA-PACIFIC
CARTILAGE REPAIR MARKET - BY PRODUCT (IN TERMS OF VALUE: IN $ MILLION)
3.1. CELL-BASED
3.2. NON-CELL-BASED
4. ASIA-PACIFIC
CARTILAGE REPAIR MARKET - BY MODALITY (IN TERMS OF VALUE: IN $ MILLION)
4.1. OSTEOCHONDRAL
ALLOGRAFT
4.2. MICROFRACTURE
& CHONDROPLASTY
4.3. JUVENILE
ALLOGRAFT FRAGMENT
4.4. AUTOLOGOUS
CHONDROCYTE IMPLANTATION
5. ASIA-PACIFIC
CARTILAGE REPAIR MARKET - BY TYPE (IN TERMS OF VALUE: IN $ MILLION)
5.1. HYALINE
CARTILAGE
5.2. FIBROCARTILAGE
6. ASIA-PACIFIC
CARTILAGE REPAIR MARKET - BY APPLICATION (IN TERMS OF VALUE: IN $ MILLION)
6.1. KNEE
6.2. OTHER
APPLICATIONS
7. ASIA-PACIFIC
CARTILAGE REPAIR MARKET - BY END-USER (IN TERMS OF VALUE: IN $ MILLION)
7.1. HOSPITAL
& CLINIC
7.2. AMBULATORY
SURGICAL CENTER
7.3. OTHER
END-USERS
8. ASIA-PACIFIC
CARTILAGE REPAIR MARKET – REGIONAL OUTLOOK (IN TERMS OF VALUE: IN $ MILLION)
8.1. COUNTRY
ANALYSIS
8.1.1. CHINA
8.1.2. JAPAN
8.1.3. INDIA
8.1.4. SOUTH
KOREA
8.1.5. AUSTRALIA
& NEW ZEALAND
8.1.6. ASEAN
COUNTRIES
8.1.7. REST
OF ASIA-PACIFIC
9. COMPETITIVE
LANDSCAPE
9.1. ARTHREX
INC
9.2. B
BRAUN MELSUNGEN AG
9.3. CONMED
CORPORATION
9.4. CRYOLIFE
INC
9.5. INTEGRA
LIFESCIENCES CORPORATION
9.6. JOHNSON
& JOHNSON
9.7. MEDTRONIC
PLC
9.8. ORGANOGENESIS
INC
9.9. OSIRIS
THERAPEUTICS INC
9.10. RTI
SURGICAL
9.11. SMITH
& NEPHEW PLC
9.12. STRYKER
CORPORATION
9.13. VERICEL
CORPORATION
9.14. ZIMMER
BIOMET HOLDINGS INC
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.1.1. OBJECTIVES
OF STUDY
10.1.2. SCOPE
OF STUDY
10.2. SOURCES
OF DATA
10.2.1. PRIMARY
DATA SOURCES
10.2.2. SECONDARY
DATA SOURCES
10.3. RESEARCH
METHODOLOGY
10.3.1. EVALUATION
OF PROPOSED MARKET
10.3.2. IDENTIFICATION
OF DATA SOURCES
10.3.3. ASSESSMENT
OF MARKET DETERMINANTS
10.3.4. DATA
COLLECTION
10.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: ASIA-PACIFIC CARTILAGE REPAIR MARKET, BY
COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: ASIA-PACIFIC CARTILAGE REPAIR MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC CARTILAGE REPAIR MARKET, BY
MODALITY, 2021-2028 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC CARTILAGE REPAIR MARKET, BY
TYPE, 2021-2028 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC CARTILAGE REPAIR MARKET, BY
APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC CARTILAGE REPAIR MARKET, BY
END-USER, 2021-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC CARTILAGE REPAIR MARKET, BY
COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: ASIA-PACIFIC CARTILAGE
REPAIR MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: PORTER’S FIVE FORCES MODEL
FIGURE 3: MARKET ATTRACTIVENESS
MATRIX
FIGURE 4: ASIA PACIFIC CARTILAGE
REPAIR MARKET, BY CELL-BASED, 2021-2028 (IN $ MILLION)
FIGURE 5: ASIA PACIFIC CARTILAGE
REPAIR MARKET, BY NON-CELL-BASED, 2021-2028 (IN $ MILLION)
FIGURE 6: ASIA PACIFIC CARTILAGE
REPAIR MARKET, BY OSTEOCHONDRAL ALLOGRAFT, 2021-2028 (IN $ MILLION)
FIGURE 7: ASIA PACIFIC CARTILAGE
REPAIR MARKET, BY MICROFRACTURE & CHONDROPLASTY, 2021-2028 (IN $ MILLION)
FIGURE 8: ASIA PACIFIC CARTILAGE
REPAIR MARKET, BY JUVENILE ALLOGRAFT FRAGMENT, 2021-2028 (IN $ MILLION)
FIGURE 9: ASIA PACIFIC CARTILAGE
REPAIR MARKET, BY AUTOLOGOUS CHONDROCYTE IMPLANTATION, 2021-2028 (IN $ MILLION)
FIGURE 10: ASIA PACIFIC CARTILAGE
REPAIR MARKET, BY HYALINE CARTILAGE REPAIR, 2021-2028 (IN $ MILLION)
FIGURE 11: ASIA PACIFIC CARTILAGE
REPAIR MARKET, BY FIBROCARTILAGE REPAIR, 2021-2028 (IN $ MILLION)
FIGURE 12: ASIA PACIFIC CARTILAGE
REPAIR MARKET, BY KNEE APPLICATION, 2021-2028 (IN $ MILLION)
FIGURE 13: ASIA PACIFIC CARTILAGE
REPAIR MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 14: ASIA PACIFIC CARTILAGE
REPAIR MARKET, BY HOSPITAL & CLINIC, 2021-2028 (IN $ MILLION)
FIGURE 15: ASIA PACIFIC CARTILAGE
REPAIR MARKET, BY AMBULATORY SURGICAL CENTER, 2021-2028 (IN $ MILLION)
FIGURE 16: ASIA PACIFIC CARTILAGE
REPAIR MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC CARTILAGE
REPAIR MARKET, REGIONAL OUTLOOK, 2020 AND 2028 (IN %)
FIGURE 18: CHINA CARTILAGE REPAIR
MARKET 2021-2028 (IN $ MILLION)
FIGURE 19: JAPAN CARTILAGE REPAIR MARKET
2021-2028 (IN $ MILLION)
FIGURE 20: INDIA CARTILAGE REPAIR
MARKET 2021-2028 (IN $ MILLION)
FIGURE 21: SOUTH KOREA CARTILAGE
REPAIR MARKET 2021-2028 (IN $ MILLION)
FIGURE 22: AUSTRALIA & NEW
ZEALAND CARTILAGE REPAIR MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: ASEAN COUNTRIES
CARTILAGE REPAIR MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: REST OF ASIA-PACIFIC
CARTILAGE REPAIR MARKET 2021-2028 (IN $ MILLION)